Literature DB >> 1398827

Osteogenesis of hydroxyapatite and tricalcium phosphate used as a bone substitute.

K Nagahara1, M Isogai, K Shibata, M A Meenaghan.   

Abstract

Hydroxyapatite (HA) and tricalcium phosphate (TCP) are useful for grafting and augmentation of bone tissue. In this study, conventional and histochemical transmission electron microscopy were used to study osteogenic events at the interface between the implanted materials and adjacent tissue from 1 to 4 weeks postoperatively. The microscopic results indicated that TCP was resorbed more rapidly than HA after implantation, with a notable breakdown of material and replacement by mesenchymal cells with ultrastructural features resembling osteoprogenitor cells and collagen up to 4 weeks postoperatively. Alkaline phosphatase and acid phosphatase reactivity in the tissues helped to identify and differentiate the histologic differences observed between HA and TCP.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1398827

Source DB:  PubMed          Journal:  Int J Oral Maxillofac Implants        ISSN: 0882-2786            Impact factor:   2.804


  3 in total

1.  Quantification of bone mass gain in response to the application of biphasic bioceramics and platelet concentrate in critical-size bone defects.

Authors:  Sonja Ellen Lobo; Francisco Henrique Lanna Wykrota; Ana Carolina Marques Barbosa Oliveira; Irina Kerkis; Germán Bohorquez Mahecha; Humberto José Alves
Journal:  J Mater Sci Mater Med       Date:  2008-12-27       Impact factor: 3.896

2.  Autogenous Bone Marrow Aspirate Coated Synthetic Hydroxyapatite for Reconstruction of Maxillo-Mandibular Osseous Defects: A Prospective Study.

Authors:  Raja Sekhar Gali; Sathya Kumar Devireddy; N Mohan Rao; R V Kishore Kumar; Sridhar Reddy Kanubaddy; Mallikarjuna Dasari; K Sowjanya; Rama Mohan Pathapati
Journal:  J Maxillofac Oral Surg       Date:  2016-06-10

3.  Fabrication of multifunctional alginate microspheres containing hydroxyapatite powder for simultaneous cell and drug delivery.

Authors:  Jueun Kim; Yeong-Jin Choi; Honghyun Park; Hui-Suk Yun
Journal:  Front Bioeng Biotechnol       Date:  2022-08-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.